Faches-Thumesnil, France

Andre Delacourte



Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2013-2015

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Andre Delacourte

Introduction

Andre Delacourte is a notable inventor based in Faches-Thumesnil, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases. With a total of 3 patents, Delacourte's work has the potential to impact the lives of many individuals suffering from these conditions.

Latest Patents

Delacourte's latest patents include innovative methods for treating neurodegenerative diseases. One of his key inventions is the use of 1,4-bis(3-aminoalkyl)piperazine derivatives for the manufacture of pharmaceutical compositions aimed at treating neurodegenerative diseases, related developmental diseases, or cancer. This invention also encompasses specific derivatives and pharmaceutical compositions that include them. Another significant patent involves heterocycle compounds designed for the prevention or treatment of diseases associated with the formation of amyloid plaques and dysfunction of APP metabolism. These compounds are crucial in addressing the underlying mechanisms of such diseases.

Career Highlights

Throughout his career, Andre Delacourte has worked with esteemed organizations, including the Institut National de la Santé et de la Recherche Médicale and Innogenetics N.V. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical research and treatment.

Collaborations

Delacourte has collaborated with notable colleagues, including Nicolas Sergeant and Luc Buee. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of neurodegenerative disease research.

Conclusion

Andre Delacourte's contributions to the field of pharmaceuticals, particularly in the treatment of neurodegenerative diseases, highlight his innovative spirit and dedication to improving healthcare. His patents and collaborations reflect a commitment to advancing medical science and providing solutions for complex health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…